← Eichor
Study identifier: NCT07005362 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Fitbit and AI Chatbot in Sedentary Primary Care Patients With T2D

Condition: Type 2 Diabetes · Type 2 Diabetes Mellitus (T2DM) · T2DM (Type 2 Diabetes Mellitus)  ·  Sponsor: University of Colorado, Denver

PhaseN/A
Planned participants36
Who can joinAll sexes, 18 Years to 80 Years
Healthy volunteersNo

About this study

The goal of this observational study is to evaluate the feasibility and acceptability of a 12-week intervention utilizing a Fitbit and artificial intelligence (AI)-delivered diabetes self-management education and support (DSMES) with tailored text messages. The main question it aims to answer is: Does providing a wearable fitness and activity tracker plus AI-tailored and DSMES improve clinical outcomes for patients with type 2 diabetes? Participants will complete a baseline visit, wear a Fitbit and answer text messages for 12-weeks, and complete by a final visit.

This description comes directly from the study's public registry record.

Talk to the study team

Jessica Parascando, MPH  ·  303-724-9525  ·  jessica.parascando@cuanschutz.edu

Elizabeth Westfeldt, BSN, RN  ·  elizabeth.westfeldt@cuanschutz.edu

Always discuss trial participation with your own doctor first.

Locations (1)

University of Colorado, AnschutzAurora, Colorado, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07005362